End Taxpayer Funding of Gender Experimentation Act of 2025
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill prohibits the use of federal funds for gender transition procedures, which it defines as hormonal treatments (including puberty blockers, testosterone, and estrogen) and surgeries (including various genital, breast, and cosmetic procedures) performed for the purpose of gender transition. The prohibition applies to direct federal spending, federal trust funds, federal employee health benefits, military healthcare, VA healthcare, Medicaid, and ACA marketplace subsidies.
Who Benefits and How
Taxpayers who object to funding gender transition care avoid having federal tax dollars used for these procedures. Health insurers may face reduced costs if transgender enrollees leave plans that exclude this coverage. Religious healthcare providers gain explicit protection from being required to provide these services through federal programs.
Who Bears the Burden and How
Transgender individuals lose access to federally-subsidized coverage for transition-related medical care. This includes federal employees, military personnel, veterans, Medicaid recipients, and anyone receiving ACA premium subsidies. They must either pay entirely out-of-pocket or purchase separate non-subsidized coverage. Healthcare providers specializing in gender transition care lose federal patients and reimbursement. Health insurers offering comprehensive coverage to transgender individuals cannot receive federal premium subsidies for those plans.
Key Provisions
- Prohibits all federal funds and trust funds from being spent on gender transition procedures
- Excludes health plans covering gender transition from ACA premium tax credits (section 36B) and small business health credits (section 45R)
- Bars federal healthcare facilities and federal employees from providing gender transition services
- Defines 30+ specific procedures as 'gender transition procedures' including puberty blockers, cross-sex hormones, and various surgeries
- Exempts treatment of disorders of sex development and treatment of complications from prior procedures
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Prohibits the use of federal funds for gender transition procedures including surgeries and hormone treatments, excludes health plans covering such procedures from ACA premium tax credits, and bars federal facilities and employees from providing these services
Key Policy Areas
Healthcare, Taxation, Federal Spending, LGBTQ Policy
Primary Purpose
Prohibits the use of federal funds for gender transition procedures including surgeries and hormone treatments, excludes health plans covering such procedures from ACA premium tax credits, and bars federal facilities and employees from providing these services
Policy Domains
Title I - Prohibition on Taxpayer-Funded Gender Transition Procedures
Identified Gains
Contextual inference, no direct clause citation- Taxpayers opposed to funding gender transition
- Religious healthcare providers
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Transgender individuals seeking federally-subsidized care
- Gender transition healthcare providers
- Federal employees and military personnel
Contextual inference, no direct clause citation
Title II - Clarifying Application of Prohibition
Identified Gains
Contextual inference, no direct clause citation- Federal Treasury
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- ACA marketplace enrollees seeking gender transition coverage
- Health insurers offering comprehensive transgender coverage
Contextual inference, no direct clause citation
Chapter 4 of Title 1 USC - Prohibiting Taxpayer-Funded Gender Transition Procedures
Identified Gains
Contextual inference, no direct clause citation- States and localities using only non-federal funds
- Private insurers offering separate coverage
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Medicaid programs (federal match prohibited)
- VA healthcare system
- Federal employee health plans
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMr. Marshall (for himself, Mrs. Hyde-Smith, Mr. Cramer, Mr. Hawley, …
Read twice and referred to the Committee on Finance.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
ACA marketplace enrollees seeking gender transition coverage, Federal employees and military personnel, General public
Federal employee health benefit plans, Health insurers offering ACA plans with transgender coverage, Medicaid managed care plans
Positive-direction: Private insurers offering non-federal coverage
Negative-direction: Federal employee health benefit plans, Health insurers offering ACA plans with transgender coverage, Medicaid managed care plans, TRICARE military health plans
Federal healthcare facilities (VA, military), Gender transition surgery centers, Indian Health Service facilities
Endocrinologists prescribing puberty blockers, Gender transition healthcare providers, Healthcare providers treating disorders of sex development
Positive-direction: Healthcare providers treating disorders of sex development
Negative-direction: Endocrinologists prescribing puberty blockers, Gender transition healthcare providers, Plastic surgeons performing gender-affirming procedures
States contracting for private coverage, States offering gender transition coverage with state-only funds
Federal Treasury (reduced tax credit outlays), US Code editors
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
Key Definitions
Terms defined in this bill
Services for disorders of sex development and treatment for infection, injury, disease or disorder caused by prior gender transition procedures are excluded
An individual who naturally has, had, will have, or would have the reproductive system that produces, transports, and utilizes eggs for fertilization
The process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with his or her sex
Any hormonal or surgical intervention for the purpose of gender transition, including puberty blockers, cross-sex hormones, and over 30 enumerated surgical procedures
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology